Please enable JavaScript to continue using this application.

Compare $INDP vs $XFOR | Chartloom

Compare

$INDP vs $XFOR

Indaptus Therapeutics Inc · X4 Pharmaceuticals Inc

INDP

Indaptus Therapeutics Inc

XFOR

X4 Pharmaceuticals Inc

Compare $INDP vs $XFOR

Comparing Indaptus Therapeutics Inc and X4 Pharmaceuticals Inc

INDPIndaptus Therapeutics Inc

XFORX4 Pharmaceuticals Inc

INDPIndaptus Therapeutics Inc

Market cap

$284M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-8.4%

52W performance

-42.7%

FCF yield

-5.2%

XFORX4 Pharmaceuticals Inc

Market cap

$274M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

28.09x

Rev growth (TTM)

-51.6%

YTD performance

-25.2%

52W performance

-12.3%

FCF yield

-32.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INDP

XFOR

Detailed metrics comparison

INDP

Indaptus Therapeutics Inc

XFOR

X4 Pharmaceuticals Inc

Market Cap

INDP$284M

XFOR$274M

Enterprise Value

INDP$277M

XFOR$156M

Price

INDP$2.51

XFOR$2.91

P/E Ratio

INDPN/A

XFORN/A

P/S Ratio

INDP0.00x

XFOR17.32x

EV/Sales

INDP0.00x

XFOR9.85x

EV/EBITDA

INDP0.00x

XFOR0.00x

P/B Ratio

INDP32.14x

XFOR1.81x

P/FCF Ratio

INDPN/A

XFORN/A

EV/FCF

INDP-18.83x

XFOR-1.76x

PEG Ratio

INDPN/A

XFORN/A

Forward P/E (NTM)

INDPN/A

XFORN/A

Forward P/S (NTM)

INDPN/A

XFOR28.09x

Revenue (TTM)

INDP$0

XFOR$16M

Revenue Growth (YoY)

INDPN/A

XFOR-51.6%

Forward Rev Growth

INDP0.0%

XFOR-27.7%

Gross Margin (TTM)

INDP0.0%

XFOR81.5%

Operating Margin (TTM)

INDP0.0%

XFOR0.0%

EBITDA Margin (TTM)

INDP0.0%

XFOR-544.2%

Net Margin (TTM)

INDP0.0%

XFOR-568.8%

FCF Margin (TTM)

INDPN/A

XFOR-560.0%

Net Income (TTM)

INDP$-15M

XFOR$-90M

FCF (TTM)

INDP$-15M

XFOR$-89M

EPS (TTM)

INDP-$0.13

XFOR-$0.71

ROE (TTM)

INDP-30275.0%

XFOR-6305.0%

ROA (TTM)

INDP-20348.0%

XFOR-3689.0%

ROIC (TTM)

INDP-30275.0%

XFOR-4109.0%

Cash

INDP$8M

XFOR$195M

Debt

INDP$0

XFOR$77M

Net Cash/Debt

INDP$8M

XFOR$118M

Current Ratio (TTM)

INDP19.48x

XFOR11.30x

Quick Ratio (TTM)

INDP18.82x

XFOR10.87x

Debt/Equity (TTM)

INDP0.00x

XFOR0.49x

Debt/Assets (TTM)

INDP0.0%

XFOR0.0%

Interest Coverage (TTM)

INDPN/A

XFORN/A

Net Debt/EBITDA (TTM)

INDP0.00x

XFOR0.00x

Beta

INDP0.99

XFOR0.50

52W Performance

INDP-42.7%

XFOR-12.3%

YTD Performance

INDP-8.4%

XFOR-25.2%

% from 52W High

INDP-57.9%

XFOR-39.8%

% from 52W Low

INDP172.8%

XFOR7.8%

Asset Turnover (TTM)

INDP0.00x

XFOR0.06x

FCF Yield (TTM)

INDP-5.2%

XFOR-32.3%

Earnings Yield (TTM)

INDP-5.4%

XFOR-32.8%

Dividend Yield (TTM)

INDPN/A

XFORN/A

Rule of 40

INDP0.0

XFOR-611.6

EV/GP/RG

INDPN/A

XFORN/A

Ticker research

View INDP research View XFOR research

Metric	INDP Indaptus Therapeutics Inc	XFOR X4 Pharmaceuticals Inc
Market & Valuation
Market Cap	$284M	$274M
Enterprise Value	$277M	$156M
Price	$2.51	$2.91
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	17.32x
EV/Sales	0.00x	9.85x
EV/EBITDA	0.00x	0.00x
P/B Ratio	32.14x	1.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.83x	-1.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	28.09x
Revenue & Growth
Revenue (TTM)	$0	$16M
Revenue Growth (YoY)	N/A	-51.6%
Forward Rev Growth	0.0%	-27.7%
Profitability
Gross Margin (TTM)	0.0%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-544.2%
Net Margin (TTM)	0.0%	-568.8%
FCF Margin (TTM)	N/A	-560.0%
Net Income (TTM)	$-15M	$-90M
FCF (TTM)	$-15M	$-89M
EPS (TTM)	-$0.13	-$0.71
ROE (TTM)	-30275.0%	-6305.0%
ROA (TTM)	-20348.0%	-3689.0%
ROIC (TTM)	-30275.0%	-4109.0%
Financial Health
Cash	$8M	$195M
Debt	$0	$77M
Net Cash/Debt	$8M	$118M
Current Ratio (TTM)	19.48x	11.30x
Quick Ratio (TTM)	18.82x	10.87x
Debt/Equity (TTM)	0.00x	0.49x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	0.50
52W Performance	-42.7%	-12.3%
YTD Performance	-8.4%	-25.2%
% from 52W High	-57.9%	-39.8%
% from 52W Low	172.8%	7.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-5.2%	-32.3%
Earnings Yield (TTM)	-5.4%	-32.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-611.6
EV/GP/RG	N/A	N/A
Ticker research	View INDP research	View XFOR research

Valuation

P/S Ratio

INDP

0.00x

XFOR

17.32x

EV/FCF

INDP

-18.83x

XFOR

-1.76x

Growth & revenue

Revenue Growth TTM

XFOR

-51.6%

Forward Revenue Growth

INDP

0.0%

XFOR

-27.7%

Profitability & performance

Gross Margin

XFOR

81.5%

INDP

0.0%

ROE

XFOR

-6305.0%

INDP

-30275.0%

FCF Yield %

INDP

-5.2%

XFOR

-32.3%

52-Week Performance

XFOR

-12.3%

INDP

-42.7%

Detailed metrics comparison

INDP

Indaptus Therapeutics Inc

XFOR

X4 Pharmaceuticals Inc

Market Cap

INDP$284M

XFOR$274M

Enterprise Value

INDP$277M

XFOR$156M

Price

INDP$2.51

XFOR$2.91

P/E Ratio

INDPN/A

XFORN/A

P/S Ratio

INDP0.00x

XFOR17.32x

EV/Sales

INDP0.00x

XFOR9.85x

EV/EBITDA

INDP0.00x

XFOR0.00x

P/B Ratio

INDP32.14x

XFOR1.81x

P/FCF Ratio

INDPN/A

XFORN/A

EV/FCF

INDP-18.83x

XFOR-1.76x

PEG Ratio

INDPN/A

XFORN/A

Forward P/E (NTM)

INDPN/A

XFORN/A

Forward P/S (NTM)

INDPN/A

XFOR28.09x

Revenue (TTM)

INDP$0

XFOR$16M

Revenue Growth (YoY)

INDPN/A

XFOR-51.6%

Forward Rev Growth

INDP0.0%

XFOR-27.7%

Gross Margin (TTM)

INDP0.0%

XFOR81.5%

Operating Margin (TTM)

INDP0.0%

XFOR0.0%

EBITDA Margin (TTM)

INDP0.0%

XFOR-544.2%

Net Margin (TTM)

INDP0.0%

XFOR-568.8%

FCF Margin (TTM)

INDPN/A

XFOR-560.0%

Net Income (TTM)

INDP$-15M

XFOR$-90M

FCF (TTM)

INDP$-15M

XFOR$-89M

EPS (TTM)

INDP-$0.13

XFOR-$0.71

ROE (TTM)

INDP-30275.0%

XFOR-6305.0%

ROA (TTM)

INDP-20348.0%

XFOR-3689.0%

ROIC (TTM)

INDP-30275.0%

XFOR-4109.0%

Cash

INDP$8M

XFOR$195M

Debt

INDP$0

XFOR$77M

Net Cash/Debt

INDP$8M

XFOR$118M

Current Ratio (TTM)

INDP19.48x

XFOR11.30x

Quick Ratio (TTM)

INDP18.82x

XFOR10.87x

Debt/Equity (TTM)

INDP0.00x

XFOR0.49x

Debt/Assets (TTM)

INDP0.0%

XFOR0.0%

Interest Coverage (TTM)

INDPN/A

XFORN/A

Net Debt/EBITDA (TTM)

INDP0.00x

XFOR0.00x

Beta

INDP0.99

XFOR0.50

52W Performance

INDP-42.7%

XFOR-12.3%

YTD Performance

INDP-8.4%

XFOR-25.2%

% from 52W High

INDP-57.9%

XFOR-39.8%

% from 52W Low

INDP172.8%

XFOR7.8%

Asset Turnover (TTM)

INDP0.00x

XFOR0.06x

FCF Yield (TTM)

INDP-5.2%

XFOR-32.3%

Earnings Yield (TTM)

INDP-5.4%

XFOR-32.8%

Dividend Yield (TTM)

INDPN/A

XFORN/A

Rule of 40

INDP0.0

XFOR-611.6

EV/GP/RG

INDPN/A

XFORN/A

Ticker research

View INDP research View XFOR research

Metric	INDP Indaptus Therapeutics Inc	XFOR X4 Pharmaceuticals Inc
Market & Valuation
Market Cap	$284M	$274M
Enterprise Value	$277M	$156M
Price	$2.51	$2.91
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	17.32x
EV/Sales	0.00x	9.85x
EV/EBITDA	0.00x	0.00x
P/B Ratio	32.14x	1.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.83x	-1.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	28.09x
Revenue & Growth
Revenue (TTM)	$0	$16M
Revenue Growth (YoY)	N/A	-51.6%
Forward Rev Growth	0.0%	-27.7%
Profitability
Gross Margin (TTM)	0.0%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-544.2%
Net Margin (TTM)	0.0%	-568.8%
FCF Margin (TTM)	N/A	-560.0%
Net Income (TTM)	$-15M	$-90M
FCF (TTM)	$-15M	$-89M
EPS (TTM)	-$0.13	-$0.71
ROE (TTM)	-30275.0%	-6305.0%
ROA (TTM)	-20348.0%	-3689.0%
ROIC (TTM)	-30275.0%	-4109.0%
Financial Health
Cash	$8M	$195M
Debt	$0	$77M
Net Cash/Debt	$8M	$118M
Current Ratio (TTM)	19.48x	11.30x
Quick Ratio (TTM)	18.82x	10.87x
Debt/Equity (TTM)	0.00x	0.49x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	0.50
52W Performance	-42.7%	-12.3%
YTD Performance	-8.4%	-25.2%
% from 52W High	-57.9%	-39.8%
% from 52W Low	172.8%	7.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-5.2%	-32.3%
Earnings Yield (TTM)	-5.4%	-32.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-611.6
EV/GP/RG	N/A	N/A
Ticker research	View INDP research	View XFOR research